alexa When is Good, Good Enough? Methodological Pragmatism for Sustainable Guideline Development: Democratization of Processes for Setting Methodological Standards for Trustworthy Clinical Practice Guidelines | Open Access Journals
ISSN: 2476-2261
Journal of Oncology Translational Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

When is Good, Good Enough? Methodological Pragmatism for Sustainable Guideline Development: Democratization of Processes for Setting Methodological Standards for Trustworthy Clinical Practice Guidelines

George P Browman1* and Melissa C Brouwers2

1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

2Department of Oncology, McMaster University, Hamilton, ON, Canada

Corresponding Author:
George P Browman
School of Population and Public Health
University of British Columbia
Vancouver, BC, Canada
E-mail: [email protected]

Received date: September 01, 2016; Accepted date: September 23, 2016; Published date: September 30, 2016

Citation: Browman GP, Brouwers MC (2016) When is Good, Good Enough? Methodological Pragmatism for Sustainable Guideline Development Democratization of Processes for Setting Methodological Standards for Trustworthy Clinical Practice Guidelines. Oncol Trans Res 2:110.

Copyright: © 2016 Browman GP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Oncology Translational Research

Keywords

Introduction

The source paper contains two main messages in response to escalating demands for methodological rigor in the development and reporting of trustworthy clinical practice guidelines [1,2]. The messages are prompted by the experiences of the authors who have worked with, and advised individuals, groups and organizations committed to evidence-based methods in guideline development and research design.

In their advisory roles, the authors have noted consistent expressions of concern by clients who were skeptical about the marginal benefits associated with ever-increasing demands from the methodological community for more exact methods that were becoming impractical and expensive to implement in pursuit of trustworthy guidelines and related clinical research [3,4]. The authors of the paper have interpreted these client concerns as a backlash against increasing methodological dominance of the evidence-based movement that risks reversal, or erosion of the gains already made in promoting evidence-based processes in clinical research and care.

Among several other points made by the authors in support of the importance of methodological rigor in the development of guidelines, the two main messages relate to: 1) whether the additional costs, labor-intensiveness, and production delays for guidelines development to meet ever-increasing methodological standards of rigor in all circumstances are worth the resulting benefits; and 2) the appropriateness of the dominance of research methodologists in prescribing standards of rigor that affect so many other stakeholder groups in various ways.

The authors point out that pursuit of ‘methodological purity’ for trustworthy guidelines ignores the imperfections of real-world circumstances , and that formulaic approaches to defining what is methodologically acceptable hinders thoughtful consideration of issues within unique, real-world contexts [1].

The centre-piece of the paper is the description of a framework (the Efficiency-Validity Methodological Continuum) that is intended to facilitate negotiated thresholds of rigor among stakeholders in determining where the risks of compromise in methodological rigor are worth improved efficiencies in guideline development. But, the framework itself is not the most important takeaway message of this paper; rather, it is the need to democratize the process for determining methodologically acceptable thresholds in which methodologists trade their roles as rule-makers for appropriate methodological standards, to mediators, or expert advisors in helping stakeholders come to negotiated solutions that balance the risks to validity of guidelines (and the potential clinical consequences) against the costs of their production to meet stakeholder needs. An important implication of this approach is that the negotiation would need to be context specific, especially in relation to stakeholder values, the risks of the clinical condition under consideration in a guideline, the characteristics of the alternative interventions available and the affordability of producing a guideline and following its recommendations within real-world settings.

In the context of a more democratic approach to setting methodological standards involving stakeholder inputs, methodologists become educators, facilitators and guardians of a process of checks and balances to minimize risks of too lax or too rigid recommendations within a local or regional context. The process is intended to allow for universal methodological standards to be taught and acknowledged, but molded to circumstances and to the values of the negotiating parties.

The use of the framework (presented as a negotiation “tool”) by negotiating parties in different jurisdictions might produce different processes, but three important methodological improvements are likely to result: 1) greater transparency in how methodological choices are made; 2) improved reporting of guideline development methods, including the processes used and the compromises made; and 3) direct research inquiry that would allow a more explicit investigation of the implications of the methods chosen on the credibility of recommendations, costs, and acceptability of the final products.

Adopting a negotiation process managed by methodologists may at first seem awkward, add administrative complexities and costs, but as reports accumulate about the experiences of stakeholders, we may learn more about how to garner the trust of all of those affected by guideline recommendations, and steadily improve the efficiency of guideline development. Finally, involving stakeholders in such processes can disseminate methodological knowledge and insights beyond the methodological community through a participatory approach that can lead to improved adherence to guideline recommendations [5]. In this context, stakeholders’ “trust” in guidelines can be based on a more sophisticated appreciation of the methods used, rather than on formulaic rules, or pronouncements of ‘expert’ judgments.

Whether democratization of the process for determining the appropriateness of negotiated methodological compromises is workable, or even acceptable to stakeholders, will not be known until such processes are tested to produce empirical evidence; but, challenging the dominance of the methodological community in making rules that affect so many other stakeholder groups may be an important thrust for the future acceptance of evidence-based guidelines, as well as continuing investments in their production. Such negotiated processes for guideline development can also make more explicit for all stakeholders involved the rationale and historical lessons that have led to the pursuit of high levels of methodological rigor, while clarifying the legitimate, but sometimes misplaced logic behind resistance to implementing key methodological strategies.

The authors’ experiences with clients seeking methodological assistance in guideline development suggest that more democratic participatory processes may serve to reverse erosion of confidence among many stakeholders in the utility of good methodology for guideline development and what some stakeholders see as an elitist approach to evidence-based guideline development.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Journals

Recommended Conferences

Article Usage

  • Total views: 7945
  • [From(publication date):
    November-2016 - Sep 20, 2017]
  • Breakdown by view type
  • HTML page views : 7880
  • PDF downloads :65
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords